Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00418522

Public ClinicalTrials.gov record NCT00418522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Six Month, Open Label, Randomized Parallel Group Trial Assessing The Impact Of Dry Powder Inhaled Insulin (Exubera) On Glycemic Control Compared To Insulin Glargine (Lantus) In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On A Combination Of Two Or More Oral Agents

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is to determine if inhaled insulin is effective in treating type 2 diabetes mellitus.

Study identification

NCT ID
NCT00418522
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
413 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2007 (Type not available)
Primary completion
Aug 2008 (Actual)
Completion
Aug 2008 (Actual)
Last update posted
Aug 11, 2026

2007 – 2008

United States locations

U.S. sites
72
U.S. states
29
U.S. cities
66
Facility City State ZIP Site status
Pfizer Investigational Site Phoenix Arizona 85051 —
Pfizer Investigational Site Tucson Arizona 85712 —
Pfizer Investigational Site Concord California 94520 —
Pfizer Investigational Site Encino California 91436 —
Pfizer Investigational Site Fresno California 93720 —
Pfizer Investigational Site Fullerton California 92835 —
Pfizer Investigational Site Long Beach California 90806 —
Pfizer Investigational Site Mission Viejo California 92691 —
Pfizer Investigational Site Pasadena California 91105 —
Pfizer Investigational Site San Diego California 92120 —
Pfizer Investigational Site San Diego California 92128 —
Pfizer Investigational Site San Luis Obispo California 93401 —
Pfizer Investigational Site Spring Valley California 91978 —
Pfizer Investigational Site Stockton California 95204 —
Pfizer Investigational Site Walnut Creek California 94598 —
Pfizer Investigational Site West Hills California 91307 —
Pfizer Investigational Site Golden Colorado 80401 —
Pfizer Investigational Site Waterbury Connecticut 06708 —
Pfizer Investigational Site Newark Delaware 19713 —
Pfizer Investigational Site Chiefland Florida 32626 —
Pfizer Investigational Site Clearwater Florida 33765 —
Pfizer Investigational Site Hollywood Florida 33023 —
Pfizer Investigational Site Kissimmee Florida 34741 —
Pfizer Investigational Site Miami Florida 33156 —
Pfizer Investigational Site Ocala Florida 34471 —
Pfizer Investigational Site Saint Cloud Florida 34769 —
Pfizer Investigational Site Winter Park Florida 32789 —
Pfizer Investigational Site Atlanta Georgia 30322 —
Pfizer Investigational Site Lawrenceville Georgia 30045-3388 —
Pfizer Investigational Site Lawrenceville Georgia 30045 —
Pfizer Investigational Site Woodstock Georgia 30189 —
Pfizer Investigational Site Boise Idaho 83702 —
Pfizer Investigational Site Hayden Lake Idaho 83835 —
Pfizer Investigational Site Indianapolis Indiana 46254 —
Pfizer Investigational Site Overland Park Kansas 66211 —
Pfizer Investigational Site Topeka Kansas 66606 —
Pfizer Investigational Site Lexington Kentucky 40503 —
Pfizer Investigational Site Louisville Kentucky 40213 —
Pfizer Investigational Site Baton Rouge Louisiana 70808 —
Pfizer Investigational Site New Orleans Louisiana 70121 —
Pfizer Investigational Site Haverhill Massachusetts 01830-6141 —
Pfizer Investigational Site Springfield Missouri 65807 —
Pfizer Investigational Site Omaha Nebraska 68131 —
Pfizer Investigational Site Las Vegas Nevada 89104 —
Pfizer Investigational Site Staten Island New York 10301 —
Pfizer Investigational Site Charlotte North Carolina 28209-3734 —
Pfizer Investigational Site Statesville North Carolina 28625 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Kettering Ohio 45429 —
Pfizer Investigational Site Maumee Ohio 43537-9402 —
Pfizer Investigational Site Toledo Ohio 43606 —
Pfizer Investigational Site Oklahoma City Oklahoma 73103 —
Pfizer Investigational Site Medford Oregon 97504 —
Pfizer Investigational Site Melrose Park Pennsylvania 19027 —
Pfizer Investigational Site Greenville South Carolina 29615 —
Pfizer Investigational Site Greer South Carolina 29651 —
Pfizer Investigational Site Spartanburg South Carolina 29303 —
Pfizer Investigational Site Milan Tennessee 38358 —
Pfizer Investigational Site Arlington Texas 76014-2010 —
Pfizer Investigational Site Beaumont Texas 77701 —
Pfizer Investigational Site Dallas Texas 75230 —
Pfizer Investigational Site Dallas Texas 75231 —
Pfizer Investigational Site Dallas Texas 75246 —
Pfizer Investigational Site El Paso Texas 79935 —
Pfizer Investigational Site Houston Texas 77008 —
Pfizer Investigational Site Houston Texas 77083 —
Pfizer Investigational Site San Antonio Texas 78229-3900 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Bennington Vermont 05201-5018 —
Pfizer Investigational Site Richmond Virginia 23249 —
Pfizer Investigational Site Federal Way Washington 98003 —
Pfizer Investigational Site Menomonee Falls Wisconsin 53051 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00418522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00418522 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →